What to synthesize? From Emil Fischer to peptidomics

Journal of Peptide Science

Volumn 9, Issue 9, 2003, Pages 553-562

  Ivanov, Vadim T ^a   Blishchenko, Elena Yu ^a   Sazonova, Olga V ^a   Karelin, Andrey A ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

Biological activity; Peptides synthesis; Peptidomics; Structure function relationship; Tissue specific peptide pool

Indexed keywords

ALPHA GLOBIN; AMINO ACID; BETA GLOBIN; CYCLODEPSIPEPTIDE; CYTOSTATIC AGENT; ENNIATIN; GLUTATHIONE; GRAMICIDIN S; GROWTH INHIBITOR; HEMORPHIN 5; INSULIN; LYPRESSIN; OXYTOCIN; PEPTIDE DERIVATIVE; PEPTIDE HORMONE; POLYPEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; VALINOMYCIN; VASOPRESSIN DERIVATIVE;

AMINO ACID SEQUENCE; DRUG ACTIVITY; DRUG DESIGN; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; ORGANIC CHEMISTRY; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; ERYTHROCYTES; HEMOGLOBINS; HISTORY, 20TH CENTURY; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN CONFORMATION; PROTEOMICS;

EID: 0141838718     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.480     Document Type: Review

References (72)

1. Fischer E. Untersuchungen über Aminosäuren, Polypeptide and Proteine (1899-1906). J. Springer: Berlin, 1906; 1-83.
2. Fischer E. Untersuchungen über Aminosäuren, Polypeptide and Proteine (1907-1909). J. Springer: Berlin, 1923; 1-21.
3. Fischer E. Aus meinem Leben. J. Springer: Berlin, 1922.
4. Abderhalden A, Fodor A. Synthese von hochmolecularen Polypeptiden aus Glykocoll und L-Leucin. Ber. 1916; 49: 561-578.
5. Hopkins FG. Glutathione: a reinvestigation. J. Biol. Chem. 1929; 84:269-320.
6. Kendall EC, Mason HL, McKenzie BF. A study of glutathione. III. The structure of glutathione. J. Biol. Chem. 1930; 87: 55-79.
7. Nicolet BH. The structure of glutathione. J. Biol. Chem. 1930; 88: 389-393.
8. Consden R, Gordon AH, Martin AJP, Synge RLM. Gramicidin S: the sequence of the amino acid residues. Biochem. J. 1947; 41: 596-602.
9. Pedersen KO, Synge RLM. Diffusion experiments on gramicidin S, tyrocidine, and gramicidin. Acta Chem. Scand. 1948; 2: 408-413.
10. Battersby AR, Craig LC. The molecular weight determination of polypeptides. J. Am. Chem. Soc. 1951; 73: 1887-1888.
11. Harington CR, Mead TH. Synthesis of glutathione. Biochem.J. 1935; 29: 1602-1611.
12. Du Vigneaud V, Miller GL. A synthesis of glutathione. J. Biol. Chem. 1936; 116 469-476.
13. Du Vigneaud V, Ressler C, Trippett J. The sequence of the amino acids in oxytocin, with a proposal for the structure of oxytocin. J. Biol. Chem. 1953; 205: 949-957.
14. Du Vigneaud V, Lawler HC, Popenoe EA. Enzymatic cleavage of glycinamide from vasopressin and a proposed structure for this pressure-antidiuretic hormone of the posterior pituitary. J. Am. Chem. Soc. 1953; 75: 4880-4881.
15. Tuppy H, Michl H. Uber die chemische struktur des oxytocine. Monatsh. Chem. 1953; 84: 1011-1020.
16. Acher R, Chauvet J. Structure of vasopressin. Biochem. Biophys. Acta 1953; 12: 487-488.
17. Sanger F, Smith LF. The structure of insulin. Endeavour 1957; 16: 48-53.
18. Sanger F. Chemistry of insulin. Br. Med. Bull. 1960; 16: 183-186.
19. Du Vigneaud V, Ressler C, Swan JM, Carleton W, Roberts CW, Katsoyarmis DG. The synthesis of oxytocin. J. Am. Chem. Soc. 1954; 76: 3115-3121.
20. Bartlett MF, Jöhl, Roeske R, Stedman RJ, Stewart FHC, Ward DN, du Vigneaud V. Studies on the synthesis of lysine-vasopressin. J. Am. Chem. Soc. 1956: 78: 2905-2906.
21. Zamyatnin AA. EROP-Moscow. Endogenous regulatory oligopeptide knowledgebase. 2002; http://erop.inbi.ras.ru.
22. Ovchinnikov YuA, Ivanov VT. The cyclic peptides: structure, conformation and function. The Proteins. Academic Press: New York, 1982; 5: 307-642.
23. Shemyakin MM, Ovchinnikov YuA, Ivanov VT. Topo-chemical studies of peptide systems. Angew. Chem. Int. Ed. Engl. 1969; 8: 492-499.
24. Goodman M, Chorev M. On the concept of linear modified retro-peptide structures. Acc. Chem. Res. 1979; 12: 1-7.
25. Chorev M, Goodman M. A dozen years of retro-inverso peptidomimetics. Acc. Chem. Res. 1993; 26: 266-273.
26. Guichard G, Benkirane N, Zeder-Lutz G, Van Regenmortel MHV, Briand J-P, Muller S. Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics. Proc. Nall. Acad. Sci. USA 1994; 91: 9765-9769.
27. Benkirane N, Guichard G, Van Regenmortel MHV, Briand J-P, Muller S. Cross -reactivity of antibodies to retro-inverso peptidomimetics with the parent protein histone H3 and chromatin core particle. Specificity and kinetic rate-constant measurements. J. Biol. Chem. 1995; 270: 11 921-11 926.
28. Briand J-P, Guichard G, Dumortier H, Muller S. Retro-inverso peptidomimetics as new immunological probes. Validation and application to the detection in rheumatic diseases. J. Biol. Chem. 1995; 270: 20 686-20 691.
29. Briand J-P, Benkirane N, Guichard G, Newman JFF, Van Regenmortel MHV, Brown F, Muller S. A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease elicits high levels of long-lasting protective neutralizing antibodies. Proc. Nail Acad. Sci. USA 1997: 94: 12 545-12 550.
30. Petit M-C, Benkirane N, Guichard G, Phan Chan Du A, Marraud M, Cung MT, Briand J-P, Muller S. Solution structure of a retro-inverso peptide analogue mimicking the foot-and-mouth disease virus major antigenic site. Structure basis for its cross-reactivity with the parent peptide. J. Biol. Chem. 1999; 274: 3686-3692.
31. Voyer N, Lamothe J. The use of peptidic frameworks for the construction of molecular receptors and devices. Tetrahedron 1995; 51: 9241-9284.
32. Mutter M, Vuilleumier S. A chemical approach to protein design - template- assembled synthetic proteins. Angew. Chem. Int. Ed. Engl. 1989; 28: 535-554.
33. Kennan AJ, Haridas V, Severin K, Lee DH, Ghadiri MR. A de novo designed peptide ligase: a mechanistic investigation. J. Am. Chem. Soc. 2001: 123: 1797-1803.
34. Martin CR, Kohli P. The emerging field of nanotube biotechnology. Nature Rev. 2003; 2: 29-37.
35. Robertson DE, Farid RS, Moser CC, Urbauer JL, Mulholland SE, Pidikiti R, Lear JD, Wand AJ, DeGrado WF, Dutton PL. Design and synthesis of multi-haem proteins. Nature 1994; 368: 425-432.
36. Choma CT, Lear JD, Nelson MJ, Dutton PL, Robertson DE, De Grado WF. Design of a heme-binding four helix bundle J Am. Chem. Soc. 1994; 116: 856-865.
37. Bryson JW, Desjarlais JR, Handel TM, De Grado WF. From coiled coils to small globulin proteins: design of a native-like three-helix bundle. Protein Set. 1998; 7: 1404-1414.
38. Kohn WD, Hodges RS. De novo design of two-helical coiled coils and bundles: models for the development of protein-design principles. Trends Biotechnol. 1998; 16: 379-389.
39. Kim Y, Zeng F, Zimmerman SC. Peptide dendrimers from natural amino acids. Chem. Eur. J. 1999; 5: 2133-2138.
40. Ivanov VT, Karelin AA, Mikhaleva II, Vaskovsky BV, Sviryaev VI, Nazimov IV. Isolation, structure and properties of new endogenous peptides. Bioorg. Khim. 1992; 118: 1271-1311.
41. Ziganshin RH, Sviryaev VI, Vaskovsky BV, Mikhaleva II, Ivanov VT, Kokoz YuM, Alekseev AE, Korystova AF, Sukhova GS, Emelyanova TG, Usenko AB. Bioactive peptides isolated from the brain of hibernating ground squirrel. Bioorg. Khim. 1994; 20: 899-918.
42. Ivanov VT, Karelin AA, Philippova MM, Nazimov IV, Pletnev VZ. Haemoglobin as a source of endogenous bioactive peptides. A concept of tissue specific peptide pool. Biopolymers Peptide Set. 1997; 43: 171-188.
43. Karelin AA, Philippova MM, Karelina EV, Strizhkov BN, Grishina GA, Nazimov IV, Ivanov VT. Peptides from bovine brain: structure and biological role. J. Pept. Set. 1998; 4: 211-225.
44. Karelin AA, Philippova MM, Yatskin ON, Kalinina OA, Nazimov IV, Blishchenko EY, Ivanov VT. Peptides comprising the bulk of rat brain extracts: isolation, amino acid sequences and biological activity. J. Pept. Set. 2000; 6: 345-354.
45. Karelin AA, Philippova MM, Karelina EV, Ivanov VT. Isolation of endogeneous hemorphin-related haemoglobin fragments from bovine brain. Biochem. Biophys. Res. Commun. 1994; 202: 410-415.
46. Karelin AA, Blishchenko EYu, Ivanov VT. A novel system of peptidergic regulation. FEBS Lett. 1998; 428: 7-12.
47. Karelin AA, Blishchenko EYu, Ivanov VT. Fragments of functional proteins: role in endocrine regulation. Neurochem. Res. 1999; 24: 1117-1124.
48. Ivanov VT, Yatskin ON, Kalinina OA, Philippova MM, Karelin AA, Blishchenko EY. Tissue-specific peptide pools. Generation and function. Pure Appl. Chem. 2000; 72: 355-363.
49. Blishchenko EYu, Mernenko OA, Ziganshin RH, Philippova MM, Karelin AA, Ivanov VT. Neokyotorphin and neokyotorphin (1-4): cytolytic activity and comparative levels in rat tissues. Biochem. Biophys. Res. Commun. 1996; 224: 721-727.
50. Yatskin ON, Philippova MM, Blishchenko EYu, Karelin AA, Ivanov VT. LVV- and VV-hemorphins: comparative levels in rat tissues. FEBS Lett. 1998; 428: 286-290.
51. Karelin AA, Philippova MM, Karelina EV, Strizhkov BN, Nazimov IV, Ivanov VT, Dantlova RA, Ashmarin IP. GABA-induced changes of the tissue-specific peptide pool of white rat brain. J. Pept. Sci. 2000; 6: 168-174.
52. Pivnik AV, Rasstrigin NA, Philippova MM, Karelin AA,, Ivanov VT. Alteration of intraerythrocytes proteolytic degradation of haemoglobin during Hodgkin's disease. Leuk. Lymphoma 1996; 22: 345-349.
53. Slemmon JR, Wengenack TM, Flood DG. Profiling of endogenous peptides as a tool for studying development and neurological disease. Biopolymers Peptides Set. 1997; 43: 157-170.
54. Glamsta EL, Marclund A, Lantz 1, Nyberg F. Concomitant increase in blood plasma levels of immunoreactive hemorphin-7 and β-endorphin following long distance running. Regul. Pept. 1994; 49: 9-18.
55. Slemmon JR, Hughes CM, Cambell GA, Flood DG. Increased levels of haemoglobin -derived and other peptides in Alzheimer's disease cerebellum. J. Neurosci. 1994; 14: 2225-2235.
56. Karelin AA, Philippova MM, Ivanov VT. Proteolytic degradation of haemoglobin in erythrocytes leads to biologically active peptides. Peptides 1995; 16: 693-697.
57. Ivanov VT, Karelin AA, Blishchenko EY, Philippova MM, Nazimov IV. Proteolytic degradation of haemoglobin in vivo. Role in formation of tissue specific peptide pool. Pure Appl. Chem. 1998; 70: 67-74.
58. Karelin AA, Filippova MM, Yatskin ON, Blishchenko EYu, Nazimov IV, Ivanov VT. Proteolytic degradation of haemoglobin in erythrocytes yields biologically active peptides. Bioorg. Khim. 1998; 24: 271-281.
59. Yatskin ON, Karelin AA, Philippova MM, Ivanov VT, Haemoglobin degradation pathways in human erythrocytes. Proceedings of the 27th European Peptide Symposium. In: Peptides 2002 Benedetti E, Pedone C, Eds. Edizioni Zimo, Napoli, Italy, 2002; 424-425.
60. Blishchenko E Yu, Mernenko OA, Yatskin ON, Ziganshin RH, Philippova MM, Karelin AA, Ivanov VT. Neokyotorphin and neokyotorphin (1-4): secretion by erythrocytes and regulation of tumour cell growth. FEBS Lett. 1997; 414: 125-128.
61. Blishchenko EYu, Mernenko OA, Mirkina II, Satpaev DK, Ivanov VS, Tchikin LD, Ostrovsky AG, Karelin AA, Ivanov VT. Tumor cell cytolysis mediated by valorphin - an opioid-like fragment of haemoglobin β-chain. Peptides 1997; 18: 79-85.
62. Zhao Q, Sannier F, Garreau I, Guillochon D, Piot J-M. Inhibition and inhibition kinetics of angiotensin converting enzyme activity by hemorphins, isolated from a peptic bovine haemoglobin hydrolysate. Biochem. Biophys. Res. Commun. 1994; 204: 216-223.
63. Brormikov G, Dolgacheva L, Zhang Sh, Galitovskaya E, Kramarova L, Zinchenko V. The effect of neuropeptides kyotorphin and neokyotorphin on proliferation of cultured brown preadipocytes. FEBS Lett. 1997; 407: 73-77.
64. Takagi H, Shiomi H, Fukui K, Hayashi K, Kiso Y, Kitagawa K. Isolation of a novel analgesic pentapeptide, neo-kyotorphin, from bovine brain. Life Sci. 1982; 31: 1733-1736.
65. Nyberg F, Sanderson K, Glamsta EL. The hemorphins: a new class of opioid peptides derived from blood protein haemoglobin. Biopolymers. Pept. Set. 1997; 43: 147-156.
66. Glamsta EL, Marclund A, Hellman U, Wernstedt C, Terenius L, Nyberg F. Isolation and characterization of a haemoglobin-derived opioid peptide from the human pituitary gland . Regul. Pept. 1991; 34: 169-179.
67. 2+ current in cardiac cells and on the activity of septal neurones. FEBS Lett. 1997; 411: 71-76.
68. Brantl V, Gramsch Ch, Lottspeich F, Mertz R, Jaeger K-H, Herz A. Novel opioid peptides derived from haemoglobin: hemorphins. Eur. J. Pharmacol. 1986; 125: 309-310.
69. Blishchenko EYu, Sazonova OV, Leontiev KV, Khaidukov SV, Sheikine YA, Sokolov DI, Freidlin IS, Yatskin ON, Philippova MM, Vass AA, Karelin AA, Ivanov VT. Components of tissue-specific peptide pools: contribution to regulation of cell number. Proceedings of the 27th European Peptide Symposium. In: Peptides 2002 Benedetti E, Pedone C, Eds. Edizioni Ziino, Napoli, Italy, 2002; 440-441. ,
70. Blishchenko, EYu, Sazonova OV, Kalinina OA, Yatskin ON, Philippova MM, Surovoy AY, Karelin AA, Ivanov VT. Family of hemorphins: co-relations between amino acid sequences and effects in cell cultures. Peptides 2002; 23: 903-910.
71. Blishchenko EYu, Sazonova OV, Surovoy AY, Khaidukov SV, Sheikine YA, Sokolov DI, Freidlin IS, Philippova MM, Vass AA, Karelin AA, Ivanov VT. Antiproliferative action of valorphin in cell cultures. J. Pept. Sci. 2002; 8: 438-452.
72. Blishchenko EYu, Kalinina OA, Sazonova OV, Khaidukov SV, Egorova NS, Surovoy AY, Philippova MM, Vass AA, Karelin AA, Ivanov VT. Endogenous fragment of haemoglobin, neokyotorphin, as cell growth factor. Peptides 2001; 22: 1999-2008.